Return On Equity of AGIOS PHARMACEUTICALS, INC. from 31 Mar 2014 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
AGIOS PHARMACEUTICALS, INC. quarterly and annual Return On Equity in % history and change rate from 31 Mar 2014 to 30 Sep 2025.
  • AGIOS PHARMACEUTICALS, INC. Return On Equity for the quarter ending 30 Sep 2025 was -28%, a 140% decline year-over-year.
  • AGIOS PHARMACEUTICALS, INC. annual Return On Equity for 2024 was 59%.
  • AGIOS PHARMACEUTICALS, INC. annual Return On Equity for 2023 was -38%, a 84% decline from 2022.
  • AGIOS PHARMACEUTICALS, INC. annual Return On Equity for 2022 was -21%, a 122% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

AGIOS PHARMACEUTICALS, INC. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -28% -99% -140% 01 Jul 2025 30 Sep 2025
Q2 2025 43% +90% 01 Apr 2025 30 Jun 2025
Q1 2025 50% +92% 01 Jan 2025 31 Mar 2025
Q4 2024 59% +97% 01 Oct 2024 31 Dec 2024
Q3 2024 70% +92% 01 Jul 2024 30 Sep 2024
Q2 2024 -47% -27% -133% 01 Apr 2024 30 Jun 2024
Q1 2024 -41% -21% -105% 01 Jan 2024 31 Mar 2024
Q4 2023 -38% -17% -84% 01 Oct 2023 31 Dec 2023
Q3 2023 -22% +9% +29% 01 Jul 2023 30 Sep 2023
Q2 2023 -20% +9% +31% 01 Apr 2023 30 Jun 2023
Q1 2023 -20% +6% +22% 01 Jan 2023 31 Mar 2023
Q4 2022 -21% -116% -122% 01 Oct 2022 31 Dec 2022
Q3 2022 -31% -141% -128% 01 Jul 2022 30 Sep 2022
Q2 2022 -29% -159% -123% 01 Apr 2022 30 Jun 2022
Q1 2022 -26% -196% -115% 01 Jan 2022 31 Mar 2022
Q4 2021 96% +159% 01 Oct 2021 31 Dec 2021
Q3 2021 110% +168% 01 Jul 2021 30 Sep 2021
Q2 2021 130% +190% 01 Apr 2021 30 Jun 2021
Q1 2021 170% +234% 01 Jan 2021 31 Mar 2021
Q4 2020 -63% +10% +14% 01 Oct 2020 31 Dec 2020
Q3 2020 -58% +12% +18% 01 Jul 2020 30 Sep 2020
Q2 2020 -60% 0% +0.3% 01 Apr 2020 30 Jun 2020
Q1 2020 -64% -16% -33% 01 Jan 2020 31 Mar 2020
Q4 2019 -73% -29% -66% 01 Oct 2019 31 Dec 2019
Q3 2019 -70% -22% -44% 01 Jul 2019 30 Sep 2019
Q2 2019 -60% -8% -16% 01 Apr 2019 30 Jun 2019
Q1 2019 -48% +14% +22% 01 Jan 2019 31 Mar 2019
Q4 2018 -44% +33% +42% 01 Oct 2018 31 Dec 2018
Q3 2018 -49% +13% +21% 01 Jul 2018 30 Sep 2018
Q2 2018 -52% +8% +13% 01 Apr 2018 30 Jun 2018
Q1 2018 -62% 0% -0.52% 01 Jan 2018 31 Mar 2018
Q4 2017 -77% -29% -60% 01 Oct 2017 31 Dec 2017
Q3 2017 -61% -8% -15% 01 Jul 2017 30 Sep 2017
Q2 2017 -60% -12% -25% 01 Apr 2017 30 Jun 2017
Q1 2017 -61% -24% -64% 01 Jan 2017 31 Mar 2017
Q4 2016 -48% -17% -58% 01 Oct 2016 31 Dec 2016
Q3 2016 -53% -28% -110% 01 Jul 2016 30 Sep 2016
Q2 2016 -48% -31% -192% 01 Apr 2016 30 Jun 2016
Q1 2016 -37% -23% -154% 01 Jan 2016 31 Mar 2016
Q4 2015 -30% -8% -35% 01 Oct 2015 31 Dec 2015
Q3 2015 -25% -2% -7.2% 01 Jul 2015 30 Sep 2015
Q2 2015 -16% +20% +55% 01 Apr 2015 30 Jun 2015
Q1 2015 -15% +43% +75% 01 Jan 2015 31 Mar 2015
Q4 2014 -22% 01 Oct 2014 31 Dec 2014
Q3 2014 -24% 01 Jul 2014 30 Sep 2014
Q2 2014 -36% 01 Apr 2014 30 Jun 2014
Q1 2014 -58% 01 Jan 2014 31 Mar 2014

AGIOS PHARMACEUTICALS, INC. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 59% +97% 01 Jan 2024 31 Dec 2024
2023 -38% -17% -84% 01 Jan 2023 31 Dec 2023
2022 -21% -116% -122% 01 Jan 2022 31 Dec 2022
2021 96% +159% 01 Jan 2021 31 Dec 2021
2020 -63% +10% +14% 01 Jan 2020 31 Dec 2020
2019 -73% -29% -66% 01 Jan 2019 31 Dec 2019
2018 -44% +33% +42% 01 Jan 2018 31 Dec 2018
2017 -77% -19% -33% 01 Jan 2017 31 Dec 2017
2016 -57% -27% -89% 01 Jan 2016 31 Dec 2016
2015 -30% -8% -35% 01 Jan 2015 31 Dec 2015
2014 -22% 01 Jan 2014 31 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.